Celularity (CELU) Times Interest Earned (2019 - 2025)
Celularity (CELU) posted quarterly Times Interest Earned of -$5.3 for Q4 2025, down 345.85% year-over-year from $2.15 in Q4 2024, and down 50.79% quarter-over-quarter from -$3.51 in Q3 2025.
Celularity (CELU) Times Interest Earned (2019 - 2025) Analysis & Trends
Celularity (CELU) has reported Times Interest Earned for 7 consecutive years, with -$5.3 the latest figure, recorded in Q4 2025.
- In Q4 2025, Times Interest Earned fell 345.85% year-over-year to -$5.3; the TTM figure through Dec 2025 stood at $45.62 (up 470.11% YoY), while the FY2025 annual figure was -$5.63, down 7.67% from the prior year.
- Times Interest Earned eased to -$5.3 in Q4 2025 per CELU's latest filing, from -$3.51 in the prior quarter.
- Across five years, Times Interest Earned topped out at $24.66 in Q4 2022 and bottomed at -$89.33 in Q1 2023.
- Historically, Times Interest Earned has averaged -$13.63 across 5 years, with a median of -$1.02 in 2023.
- Annual changes were most pronounced in 2022 — Times Interest Earned surged 273.77% — and 2025, when it sank 2936.59%.
- Celularity's Times Interest Earned stood at $6.6 in 2021, then surged by 273.77% to $24.66 in 2022, then plunged by 122.98% to -$5.67 in 2023, then soared by 138.0% to $2.15 in 2024, then slumped by 345.85% to -$5.3 in 2025.
- Business Quant data shows CELU's Times Interest Earned at -$5.3 in Q4 2025, -$3.51 in Q3 2025, and -$0.23 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | 1.42 |
| 10 | Celularity | 20.79 Mn | 14.61 Mn | -3.27 Mn | -24.59 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.30 |
| Sep 30, 2025 | -3.51 |
| Jun 30, 2025 | -0.23 |
| Mar 31, 2025 | -1.45 |
| Dec 31, 2024 | 2.15 |
| Sep 30, 2024 | -0.12 |
| Jun 30, 2024 | -0.14 |
| Mar 31, 2024 | -6.43 |
| Dec 31, 2023 | -5.67 |
| Sep 30, 2023 | -1.29 |
| Jun 30, 2023 | -0.76 |
| Mar 31, 2023 | -89.33 |
| Dec 31, 2022 | 24.66 |
| Sep 30, 2022 | -0.07 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | -58.78 |
| Dec 31, 2021 | 6.60 |
| Sep 30, 2021 | 0.11 |
| Jun 30, 2021 | -74.19 |
| Mar 31, 2021 | -59.04 |